Semnur Pharmaceuticals, Inc.
SMNR
$8.00
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 95.96% | -15,174.67% | -50.23% | 14.30% | 40.22% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.55% | 117,708.40% | 29.35% | -32.85% | -9.87% |
| Change in Net Operating Assets | -94.93% | 794.69% | 559.77% | 122.66% | -206.37% |
| Cash from Operations | -69.17% | -895.15% | 167.17% | 71.64% | -231.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -155.03% | 468.80% | 5.53% | 156.73% | -154.25% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 245.60% | -244.01% | -81.58% | -123.39% | 200.00% |
| Cash from Financing | 63.81% | 1,082.27% | -155.84% | -71.98% | 233.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -316.67% | -37.50% | 1,060.00% | -400.00% | 50.00% |